Confirmatory Auditory Brainstem Responses Testing Results in Discordant Outcomes: Implications for Timely Care.

Autor: Tunkel AE; School of Medicine and Health Sciences, George Washington University, Washington, District of Columbia, U.S.A., Gorelik D; School of Medicine and Health Sciences, George Washington University, Washington, District of Columbia, U.S.A., Behzadpour HK; Department of Otolaryngology, Children's National Hospital, Washington, District of Columbia, U.S.A., Rana MS; Department of Surgery, Children's National Hospital, Washington, District of Columbia, U.S.A., Ambrose T; Division of Hearing and Speech, Children's National Hospital, Washington, District of Columbia, U.S.A., Kronzek E; Division of Hearing and Speech, Children's National Hospital, Washington, District of Columbia, U.S.A., Preciado DA; Department of Otolaryngology, Children's National Hospital, Washington, District of Columbia, U.S.A., Reilly BK; Department of Otolaryngology, Children's National Hospital, Washington, District of Columbia, U.S.A.
Jazyk: angličtina
Zdroj: The Laryngoscope [Laryngoscope] 2023 Dec; Vol. 133 (12), pp. 3571-3574. Date of Electronic Publication: 2023 Mar 21.
DOI: 10.1002/lary.30670
Abstrakt: Objectives: The purpose of this study is to evaluate for discrepancies in diagnostic auditory brainstem responses (ABR) between Children's National Hospital (CNH), a pediatric medical center, and outside facilities (OSF) that referred patients to CNH for confirmatory evaluation. Such discrepancies impact early hearing detection and intervention (EHDI) timelines.
Methods: A retrospective chart review was conducted from an internal database of patients who underwent diagnostic ABR from 2017 to 2021. Only patients with ABR results from both CNH and OSF were analyzed. Demographic data, external and internal test results, and intervention data were obtained. Hearing loss (HL) severity was graded on a scale of 0 to 8, where 0 indicated normal hearing and 8 indicated profound. Each ear was analyzed separately.
Results: Forty-nine patients met the inclusion criteria, and each ear was evaluated separately. Median HL severity was 1.0 [0.0, 4.3] at CNH compared to 3.0 [1.8, 6] at OSF (p = 0.004). Forty-seven ears (48.0%) showed lower severity at CNH. Twenty-seven patients (55%) received hearing amplification devices. The median age at time of hearing intervention was 220 days.
Conclusion: Our results showed statistical significance in the median severity of HL between CNH and OSF. A substantial proportion (70%) of children in our dataset who received amplification via cochlear implant or hearing aids were shown to have discrepancies in ABR findings from CNH and OSF. These findings have implications with regards to the appropriate usage of health care resources and maintaining EDHI timelines.
Level of Evidence: 4 (Retrospective Cohort Study) Laryngoscope, 133:3571-3574, 2023.
(© 2023 The American Laryngological, Rhinological and Otological Society, Inc.)
Databáze: MEDLINE
Externí odkaz: